Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
TARS holding history
Tarsus Pharmaceuticals, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TARS overviewAll 13F holders of TARSFull Q2 2026 holdings
- Shares (Q2 2026)
- 479,266
- Value
- $30.2M
- % of portfolio
- 0.1%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 479,266 | $30.2M | 0.1% | −363,047−43.1% | Reduced | Holders |
| Q1 2026 | 842,313 | $59.1M | 0.2% | −13,332−1.6% | Reduced | Holders |
| Q4 2025 | 855,645 | $70.1M | 0.2% | −129,984−13.2% | Reduced | Holders |
| Q3 2025 | 985,629 | $58.6M | 0.2% | −9,796−1.0% | Reduced | Holders |
| Q2 2025 | 995,425 | $40.3M | 0.1% | −336,276−25.3% | Reduced | Holders |
| Q1 2025 | 1,331,701 | $68.4M | 0.2% | +51,714+4.0% | Added | Holders |
| Q4 2024 | 1,279,987 | $70.9M | 0.2% | +685,111+115.2% | Added | Holders |
| Q3 2024 | 594,876 | $19.6M | 0.1% | +131,636+28.4% | Added | Holders |
| Q2 2024 | 463,240 | $12.6M | <0.1% | +381,014+463.4% | Added | Holders |
| Q1 2024 | 82,226 | $2.99M | <0.1% | +82,226 | New | Holders |